Lifecare ASAFRA:LFC0 8 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates FRA:LFC0 with a GF Score™ of 8/100 and a GF Value™ of €0.01 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Lifecare ASA ranks worse than 100% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Lifecare ASA's Net Income for the
three
months ended in Mar. 2026 was €-3.29 Mil. Lifecare ASA's Revenue for the
three
months ended in Mar. 2026 was €0.00 Mil. Therefore, Lifecare ASA's net margin for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Lifecare ASA's Net Margin % or its related term are showing as below:
FRA:LFC0'
s Net Margin % Range Over the Past 10 Years
Min: -127203.74 Med: -1860.93 Max: -253.78
Current: -127203.74
FRA:LFC0's Net Margin % is ranked worse than 100% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.09
vs FRA:LFC0: -127203.74
Lifecare ASA (FRA:LFC0) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Lifecare ASA Net Margin % Related Terms
Lifecare ASA Net Margin % Historical Data
* Premium members only.
The historical data trend for Lifecare ASA's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:LFC0 vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Lifecare ASA's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lifecare ASA Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lifecare ASA's Net Margin % distribution charts can be found below:
* The bar in red indicates where Lifecare ASA's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lifecare ASA (FRA:LFC0) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Lifecare ASA and its competitors. According to the industry distribution chart, Lifecare ASA ranks #817 out of 817 companies in the Medical Devices & Instruments industry.
Is Lifecare ASA's Net Margin % too high?
Lifecare ASA's current Net Margin % is 0.00%. Based on the distribution chart, Lifecare ASA ranks #817 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Lifecare ASA has a GF Score™ of 8/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lifecare ASA's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lifecare ASA ranks #817 out of 817 companies for Net Margin %. This places Lifecare ASA in the lower half of its industry. The industry median Net Margin % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Lifecare ASA and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lifecare ASA's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecare ASA stock overvalued right now?
Based on GuruFocus' analysis, Lifecare ASA (FRA:LFC0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.01, compared to a current price of €0.03 — trading 150% above its estimated fair value. The current Net Margin % is 0.00%. Lifecare ASA's overall GF Score™ is 8/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Lifecare ASA (FRA:LFC0), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lifecare ASA (FRA:LFC0) Overvalued in 2026?
Based on GuruFocus' analysis, Lifecare ASA stock appears to be overvalued.
The current stock price of €0.03 is trading 150% above its estimated GF Value™ of €0.01.
GuruFocus considers Lifecare ASA to be Significantly Overvalued.
Key valuation signals for FRA:LFC0:
Net Margin %: 0.00%
GF Value™: €0.01 vs. price of €0.03 (150% above fair value)
No single metric tells the full story. See the FRA:LFC0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. It is focused on advancing continuous glucose monitoring systems and uses osmotic pressure as a sensing method. Its technology can be applied to detect and monitor various analytes and molecules in humans and animals. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.
8GF Score
Get the complete analysis for FRA:LFC0
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LFC0 has been successfully added to your 
